For best experience please turn on javascript and use a modern browser!
Bekijk de site in het Nederlands

Hemophilia A is an inherited bleeding disorder that results in a deficiency in the clotting factor VIII. Alice van Velzen focuses on the risk factors for a dangerous complication associated with hemophilia A, which is the development of antibodies that inhibit factor VIII activity. Her aim is to provide insight into the risk factors and treatment options for inhibtor development in patients with less severe forms of hemophilia A.

Event details of Risk factors and treatment of nonsevere hemophilia A
Date 7 July 2016
Time 12:00 -13:00
Location Agnietenkapel
Room Location

A.S. van Velzen: Insight in Risk Factors and Treatment of Inhibitors in Nonsevere Hemophilia A.

Supervisors

Prof. C.J. Fijnvandraat

Prof. T.W. Kuijpers

Co-supervisor

Dr M. Peters

Agnietenkapel

Room Location

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam

Entrance

This event is open to the public.